Local inflammation as a mediator of migraine and tension-type headache

Headache

Volumn 44, Issue 8, 2004, Pages 767-771

  Friedman, Mark H ^a,b,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

^c Westchester Hd and Neck Pain Center   (United States)

Author keywords

Inflammation; Intraoral tenderness; Migraine; Tension type headache; Topical nonsteroidal anti inflammatory drugs

Indexed keywords

ANALGESIC AGENT; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SUMATRIPTAN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; EMERGENCY WARD; FEMALE; GEL; GINGIVA DISEASE; HEADACHE; HUMAN; INDUCED HYPOTHERMIA; INFLAMMATORY DISEASE; JAW DISEASE; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MAXILLARY GINGIVAL INFLAMMATION; MIGRAINE; NAUSEA; PALPATION; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TEMPERATURE MEASUREMENT; TENSION HEADACHE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY TEMPERATURE; CRYOTHERAPY; FEMALE; GELS; GINGIVITIS; HUMANS; KETOPROFEN; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREGNANCY; TENSION-TYPE HEADACHE;

EID: 4744353376     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04143.x     Document Type: Article

References (23)

1. Rasmussen BK, Jensen R. J Clin Epidemiol. 1991;44:1147-1157.
2. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin. 1990;8:801.
3. Edvinsson L, Goadsby PJ. Neuropeptides in headache. Eur J Neurol. 1998;5:329-341.
4. Jensen R, Olesen J. Tension-type headache: an update on mechanism and treatment. Curr Opin Neurol. 2000;13:285-289.
5. 3H ketanserin binding in tension-type headache. Headache. 2003;43:103-108.
6. Saper JR, Silberstein S, et al. Handbook of Headache Management, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1999:192.
7. Material Reviewed by the US Food & Drug Administration, for approval of an intraoral chilling device. Approval granted June 10, 1996 and May 7, 2004 for migraine treatment.
8. Friedman MH, Luque AF, Larsen EA. Ipsilateral intraoral tenderness and increased local tenderness and elevated temperature during unilateral migraine and tension-type headache. Headache Q. 1997;8:341-344.
9. Friedman MH, Nelson AJ. Head and neck pain review: traditional and new perspectives. J Orthop Sports Phys Ther. 1996;24:268-278.
10. Friedman MH. Atypical facial pain: the consistency of ipsilateral intraoral tenderness and elevated temperature. JADA. 1995;126:855-860.
11. Johnstone DR, Templeton M. The feasibility of palpating the lateral pterygoid muscle. J Prosthet Dent. 1980;44:318-323.
12. Friedman MH, Weisberg J, Agus B. Neglected conditions producing preauricular and referred pain. J Neurol Neurosurg Psychiatry. 1983;46:1067-1072.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
14. Friedman MH, Nehrbauer NJ, Larsen EA. An alternative approach to acute headache treatment: An emergency department pilot study. Headache Q. 1999;10:131-134.
15. Friedman MH, Peterson SJ, Behar CF, Zaidi Z. Intraoral chilling versus oral sumatriptan for acute migraine. Heart Dis. 2001;3:357-361.
16. Friedman MH, Peterson SJ, Frishman WH, Behar CF. Intraoral topical nonsteroidal drug application for headache prevention. Heart Dis. 2002;4:212-215.
17. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci. 1987;7:4129-4136.
18. Trowbridge HO, Emling RC. Inflammation: A review of the process. 5th ed. Chicago: Quintessence Publishing; 1997:3-9.
19. Silberstein SD, Lipton RB, Goadsby PJ, Smith RT. Headache in primary care. Oxford: Isis Medical Media; 1999:85.
20. Friedman MH, Peterson SJ. Intraoral migraine treatment in a medically compromised patient: a case report. Conn Med. 2001;65:707-709.
21. Solomon S. A review of mechanisms of response to pain therapy: why voodoo works. Headache. 2002;42:656-662.
22. Ryan RE, Elkind A, Goldstein J. Twenty-four hour effectiveness of BMS 180048 in the acute treatment of migraine headaches. Headache. 1997;37:245-248.
23. Tepper SJ. Tepper SJ. Abstracts and Citations. Headache. 2003;43:831.